Skip to main content
Screener/Healthcare/Biotechnology

BBIO — BridgeBio Pharma, Inc.

NASDAQ
$74.82+4.07 (+5.75%)
Large CapHealthcareFastest GrowingHigh ROE
$60.22
$93.42
$71.90
$75.85
EPS (TTM)$-3.75
P/E Ratio-18.84
Dividend Yield—
Market Cap$13.32B
Volume4.17M
Prev Close$70.73
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$180.6M-$164.0M$-0.8498.8%-90.8%
Q4 '25$154.2M-$197.2M$-1.0090.0%-127.9%
Q3 '25$120.7M-$182.7M$-0.9694.6%-151.4%
Q2 '25$110.6M-$181.9M$-0.9596.7%-164.5%
Q1 '25$116.6M-$167.4M$-0.8897.7%-143.5%
Q4 '24$5.9M-$265.1M$-1.4064.6%-4506.1%
Q3 '24$2.7M-$162.0M$-0.8678.1%-5931.2%
Q2 '24$2.2M-$73.5M$-0.3972.4%-3388.2%
Get Your Daily Market Recap